Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-03-21
1986-01-28
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548452, 548467, 546272, C07D20952, A61K 3140
Patent
active
045671958
ABSTRACT:
Azaprostacyclins of Formula I ##STR1## wherein R.sub.1 is hydrogen, alkyl, cycloalkyl, aryl, a heterocyclic residue, or a phenacyl residue optionally substituted on the phenyl ring by bromine, phenyl, alkoxy, or dialkoxy,
REFERENCES:
patent: 4097489 (1978-06-01), Bundy
patent: 4211706 (1980-07-01), Bundy
patent: 4315013 (1982-02-01), Skuballa et al.
patent: 4496742 (1985-01-01), Smith
Bundy et al., Tetrahedren Letters, No. 16, pp. 1371-1374, (1978).
Casals-Stenzel Jorge
Schillinger Ekkehard
Schwarz Norbert
Skuballa Werner
Town Michael H.
Gerstl Robert
Schering Aktiengesellschaft
LandOfFree
Azaprostacyclins, their preparation and pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaprostacyclins, their preparation and pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaprostacyclins, their preparation and pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1306539